Lv41
460 积分 2026-10-22 加入
760 A PHASE III CLINICAL TRIAL WITH A NASAL VACCINE CONTAINING BOTH HBsAg AND HBcAg IN PATIENTS WITH CHRONIC HEPATITIS B
5分钟前
已完结
Sequential combination therapy with IFN, rhIL-2 and therapeutic vaccine enhanced HBsAg loss in entecavir-suppressed CHB patients (the Endeavor study): an interim analysis
20分钟前
已完结
Sa1015 Long Duration of Effect From RNAI Therapeutic to Treat Chronic Hepatitis B Virus Infection Correlates With Persistence of the Phosphorylated Guide Strand
1小时前
已完结
LBO‐02: Utility of a new HBV RNA assay in HBeAg positive and negative CHB and following HBsAg seroclearance in patients treated with ARC‐520, an RNAi drug targeting cccDNA derived HBV mRNA
2小时前
已完结
Safety and antiviral activity of RBD1016, a RNAi therapeutic, in Chinese subjects with chronic hepatitis B virus (HBV) infection
2小时前
已完结
皖公网安备34019202002308
